Noronex (NRX) has received an A$1.25 million tranche payment from the sale of its non-core Witvlei Project, bolstering its treasury and funding ongoing exploration efforts in Namibia and Botswana. This is the first of potentially three payments for the project.
Witvlei Project Sale Delivers Cash
Noronex received A$1.25 million as the first tranche payment for its Witvlei Project. The company's cash receipt from this tranche is A$1.0 million, with 60% of the Larger Interests Payment (LIP) transferred to JEM. JEM will assume all expenditure obligations for the Witvlei licences, which are subject to an ongoing Mining Licence Application.
Future Payments and Royalties Detailed
A second tranche payment of A$1.25 million is contingent upon the grant of the Mining Licence. A further A$2.0 million remains as Deferred Consideration, payable via a 2% Net Smelter Royalty (NSR) once production commences. The total potential proceeds from the Witvlei sale, including tranches and NSR, could reach A$4.5 million.
Strategic Rationale and Funding Impact
The transaction aligns with Noronex's strategy to rationalise non-core assets. Proceeds will strengthen the company's balance sheet and fund exploration activities in Namibia and Botswana. JEM's assumption of expenditure obligations reduces Noronex's cost burden on the Witvlei licences.
Exploration Context in Namibia
The company continues to advance its exploration programs in Namibia, focusing on copper and uranium targets. Recent activities include a gravity survey at the Cgae Cgae project and the commencement of maiden drilling at the Etango North uranium project. These efforts are supported by strategic partnerships, including an earn-in agreement with South32 for the Kalahari Copper Belt tenements.
Asset Sale Bolsters Exploration Funding
Noronex's sale of the Witvlei Project provides an immediate cash injection, strengthening its financial position to support ongoing and future exploration initiatives in Namibia and Botswana. The deal de-risks the Witvlei asset, with future upside preserved through a potential NSR, while allowing Noronex to focus on higher-potential copper and uranium targets.
